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Background: Catheter ablation can reduce episodes of ventricular tachycardia (VT) after myocardial
infarction (MI). However, the optimal endpoint of the ablation procedure remains unclear.
Methods: Fifty-one consecutive patients who received catheter ablation for VT after MI were included.
The procedures targeted the isthmus of all the induced, sustained VTs. When the patients with induced
VTs were hemodynamically stable, radiofrequency energy was delivered at the mid-diastolic potential
recording site during VT. When the patients with VTs were hemodynamically unstable, the critical
channel was identiﬁed at the delayed potential recording site, showing a good pace map, with a long
stimulus-QRS interval. We delivered radiofrequency energy along the identiﬁed isthmus and across the
exit of the circuit.
Results: At the end of the procedure, all VTs became non-inducible in 30 patients (59%) and some VTs
were inducible in 21 patients (41%). During a mean of 40729 months of follow-up, no VT or ventricular
ﬁbrillation recurred in 24 patients (80%) in the non-inducible group and in 12 patients (57%) in the
inducible group, respectively (P¼0.03). The identiﬁcation of the channel during VT mapping tended to
associate with no recurrence, although the difference was not statistically signiﬁcant (P¼0.2). Fourteen
patients (27%) died during the follow-up period, mostly due to non-cardiac causes.
Conclusions: The catheter ablation targeting the isthmus of prior-MIVT and non-inducibility at the end of
the procedure can provide a satisfactory follow-up result.
& 2016 Japanese Heart Rhythm Society. Published by Elsevier B.V. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
For patients diagnosed with a prior myocardial infarction (MI),
ventricular tachycardia (VT) is a life-threatening co-morbidity.
Although implantable cardioverter deﬁbrillators (ICDs) have been
shown to reduce the risk of sudden death [1], they cannot by
themselves, prevent the occurrence of arrhythmias. Recently,
catheter ablation of ventricular tachycardia has been emerging as
an effective therapy [2], but the optimal target and endpoint of the
procedure are still controversial.
The efﬁcacy of radiofrequency catheter ablation (RFCA) for VT
in the setting of a structural heart disease was commonly deﬁned
by arrhythmia inducibility with programmed electrical stimula-
tion, at the end of the procedure. Abolition of late potential (LP)
has recently been proposed to reduce the risk of VT recurrencesblished by Elsevier B.V. This is an
kura Memorial Hospital, 3-2-
ka, Japan.
kunaga).and to provide a better follow-up outcome [3]. However, an
extensive management of all abnormal local electrical activity
within scar tissue requires prolonged procedure time and might
lead to greater myocardial damage or adverse events.
We hypothesized that patients with prior-MI showed improved
freedom from recurrent VT, if RF current was delivered to the
critical channel of the reentry circuit, not to all LPs. This study
sought to clarify the optimal procedure end point and the long-
term follow-up data on catheter ablation for prior-MI.2. Material and methods
2.1. Study subjects
This study included 51 consecutive patients (six females, mean
age 65.5711.4 years) undergoing RFCA of VT due to a prior MI
(prior MIVT), between September 2004 and August 2012. The
locations of the previous MIs were the inferior region in 26
patients, anterior in 22, and both in 3 patients. The mean leftopen access article under the CC BY-NC-ND license
Table 1
Clinical Characteristics of the Study Patients
Total (n¼51) Non-induci-
ble (n¼30)
Inducible
(n¼21)
p Value
Age, mean 7 SD 69.5711.5 69.5711.1 69.7712.2 0.94
Male 45 (88%) 27 (90%) 18 (86%) 0.68
Ejection fraction
(%), mean 7 SD
33.279.5 34.3710.3 31.778.0 0.34
Previous ICDa (%) 16 (31%) 9 (33%) 7 (33%) 1.0
Localization of
infarction
Anterior (%) 22 (43%) 10 (33%) 12 (57%)
Inferior (%) 26 (51%) 18 (60%) 8 (38%)
Anterior and Infer-
ior (%)
3 (6%) 2 (7%) 1 (5%)
History of ESb 12 (24%) 9 (33%) 3 (14%) 0.31
Use of amiodarone
(%)
26 (51%) 13 (43%) 14 (67%) 0.15
Use of sotalol (%) 3 (6%) 3 (10%) 0 0.25
Use of β blocker (%) 36 (71%) 24 (80%) 14 (67%) 0.34
Use of ACE-I c or
ARB d (%)
35 (69%) 22 (73%) 15 (71%) 0.71
Data are presented as the mean7SD or n (%)
a ICD ¼ implanted cardioverter deﬁbrillator;
b ES ¼ electrical storm;
c ACEI ¼ angiotensin-converting enzyme inhibitor;
d ARB ¼ angiotensin receptor blocker.
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patients had an ICD and seven had a cardiac resynchronization
therapy with deﬁbrillator (CRT-D). Twenty-six of the 51 patients
had received long-term (42 months) therapy with amiodarone,
and three had been treated with sotalol. Electrical storms (ESs)
had occurred in 12 patients. An ES was deﬁned as the occurrence
of three episodes of VT separated by 5 min during a 24-h period,
each resulting in an appropriate shock by the ICD [4]. Written
informed consent was obtained before the procedure, from all of
the patients. This study was approved by the ethical committee of
Kokura Memorial Hospital.
2.2. Electrophysiological study
The procedure was performed under local anesthesia. A quadri-
polar catheter was placed via the femoral vein into the right
ventricular apex. Patients underwent a routine electro-
physiological evaluation before and after the VT ablation. The sti-
mulation protocol recommended to induce VTs with up to two
extra stimuli during pacing, at two cycle lengths (400 ms and
500 ms), from two right ventricular sites (right ventricular apex
and right ventricular outﬂow tract). Isoproterenol infusion was
titrated to increase the sinus rate by 25% [5]. The endpoint of the
stimulation was the ﬁnal stimulus reaching the refractory period,
or initiation of sustained VT or ventricular ﬁbrillation (VF).
2.3. Mapping and ablation
A conventional computerized electrophysiological system and
CARTO (Biosense Webster, Diamond Bar, CA, USA) electro-
anatomical mapping system were used in all cases. Mapping and
ablation were performed using 7F steerable catheters with either a
conventional 8 mm tip (Ablaze; Japan Lifeline, Tokyo, Japan or
Navistar; Biosense-Webster, Diamond Bar, CA, USA) or a 3.5 mm
irrigated tip electrode (ThermoCool; Biosense-Webster, Diamond
Bar, CA). The standard access to the left ventricle was retrograde,
across the aortic valve. In some patients, an ante-grade trans-
septal access was used, because of severe atherosclerosis of the
aorta or peripheral arteries.
The main target of our ablation was the isthmus of all the
induced, sustained VTs. RF applications targeted the putative
channels within the low-voltage area, from the identiﬁed isthmus
to the exit of the circuit. When the induced VTs were hemody-
namically stable, VT mapping and ablation were performed with
conventional entrainment pacing at sites with diastolic potentials,
according to the methods previously described by Stevenson et al
[6]. When the induced VTs were hemodynamically unstable,
mapping and ablation was done during sinus rhythm, with long
pacing latency from the QRS onset, at sites with delayed potentials
identical to the induced VT morphology [7]. The conventional RF
applications were delivered using a temperature-controlled mode
(maximum 60 °C; maximum 180 s; 30–50 W; Stockert: Biosense-
Webster or CABL-IT: Japan Lifeline). For the irrigated tip catheters,
RF applications at 30–50 W were applied with a temperature limit
of 43 °C. For systemic anticoagulation, repeat bolus injections of
heparin based on activated clotting time measurements were
given (target value 4250 s).
Procedural success was deﬁned as the achievement of the non-
inducibility of the induced VTs before the procedure, but allowing
for the induction of a non-clinical, hemodynamically unstable VT
or VF. Recurrence was deﬁned by documentation of any sustained
VT, VF or ICD shocks. Follow-up was provided at least every
6 months, by ICD check, examination, or contacts by telephone.2.4. Statistical analysis
All measured data are reported as the mean7SD. In all cases,
the statistics were calculated using non-parametric tests (Mann–
Whitney, x2) and the Fisher’s exact method, because the data set
was small. A two-tailed probability of po0.05 was regarded as
signiﬁcant. The P-values were individually interpreted as
exploratory. Statistical analysis was performed using JMPs 10.0.0
software (SAS Institute Inc., Cary, NC, USA).3. Results
During the initial electrophysiological study, at least one
monomorphic VT was induced in 49 (96%) of the 51 patients. VT
mapping was obtained in 27 patients (53%), while substrate
mapping was obtained in 24 patients, because of hemodynamic
stability or the non-inducibility of a sustained VT. Procedural
success was obtained in 49 of the 51 patients (96%). Forty-two
patients (82%) received an ICD implant after ablation and 35
patients (69%) were administered amiodarone. At the end of the
procedure, all VTs were non-inducible in 30 patients, non-clinical
hemodynamically unstable VT was inducible in 19 patients, and
clinical VT was still inducible in 2 patients. According to the
inducibility, the patients were divided into two groups
(Figs. 1 and 2).
The patient characteristics and electrophysiological data are
listed in Tables 1 and 2. There were no signiﬁcant differences
between the two groups regarding age, gender, location of
infarction, history of ES, and LVEF (34.3% vs. 31.7%; P¼0.34). The
average number of induced VTs before the ablation was sig-
niﬁcantly larger in the induced group (1.871.2 vs. 2.971.9;
P¼0.02). The procedure time and the number of RF applications
were also signiﬁcantly larger in the induced group. The identiﬁ-
cation of the channel during VT mapping was more likely in the
non-inducible result group (50% vs. 19%; P¼0.04). The location and
electrogram amplitude of the critical channel is shown in Table 3.
Majority of the critical channels were located in the scar area, with
a signal amplitude o0.5 mV on electrogram. No mitral isthmus VT
was found in this study.
Table 2
Procedural data.
Total (n¼51) Non-inducible (n¼30) Inducible (n¼21) p Value
Cycle length of induced VT (ms) 388784 395785 352767 0.08
Induced VTs, n/patient 2.271.6 1.871.2 2.971.9 0.02
VTa mapping (%) 27 (53%) 18 (60%) 9 (43%) 0.27
Identiﬁcation of the channel in VT mapping (%) 19 (37%) 15 (50%) 4 (19%) 0.04
Mapping point, n 151750 143749 163750 0.14
Size of low voltage area (cm2) 36.2721.5 36.9723.2 35.3719.5 0.8
Fluoroscopy time, min 29714 27713 32716 0.24
Procedure time, min 193745 177740 217742 0.001
RF lesion, n 18711 1679 22712 0.03
Irrigated RFb catheter (%) 27 (53%) 16 (53%) 11 (52%) 1.0
Follow-up time after hospital discharge (months) 41729 40726 42734 0.84
Total number of patients with ICDc after ablation (%) 42 (82%) 23 (77%) 19 (90%) 0.27
Amiodarone after ablation (%) 35 (69%) 18 (69%) 17 (81%) 0.14
Data are presented as the mean7SD or n (%).
a VT¼ventricular tachycardia;
b RF¼radiofrequency;
c ICD¼ implanted cardioverter deﬁbrillator.
Table 3
Location and local electrogram amplitude of the critical channel.
Total
(n¼51)
Anterior
(n¼22)
Inferior
(n¼26)
Anterior and
inferior (n¼3)
Amplitude of the
critical channel
o0.1 mV 2 0 2 0
0.1–0.5 mV 14 5 8 1
0.5–1.5 mV 3 3 0 0
Mean value of the
amplitude (mV)
0.30 0.38 0.23 0.41
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VT or VF was observed more frequently in the non-inducible group
(24 of 30 (75%)) than in the inducible group (9 of 21 (43%),
P¼0.03). The estimated cumulative freedom from VT or VF was
88%, 83%, 75%, and 55% at the 1-, 2-, 3-, and 5-year follow-up visits
(96%, 88%, 83%, and 69% in the non-inducible result group and 75%,
75%, 64%, and 39% in the inducible result group, respectively). A
Kaplan–Meier curve of the freedom from VT or VF is shown in
Fig. 3. The identiﬁcation of the channel during VT mapping tended
to associate with freedom from the recurrence, although the dif-
ference was not statistically signiﬁcant (P¼0.2) ( Fig. 4).
Fourteen patients (27%) died during the follow-up period due
to the following reasons: sudden death (4), infection (3), carci-
noma (2), renal failure (1), senility (1), and unknown, but not
sudden death (3). There were no signiﬁcant differences between
the two groups in regards to all-cause mortality (Fig. 5). Sudden
death occurred in two patients in the non-inducible group and
two in the inducible group. An ICD was implanted in all four
patients, but ICD activities were logged in only one patient. One
patient was suspected to have died due to heart failure (patient
was frequently hospitalized) and the other two patients died due
to unknown causes. In terms of complications associated with
procedure, one stroke occurred within 24 hours after the proce-
dure, in a patient with an ES.4. Discussion
4.1. Main ﬁndings
The main ﬁndings of this study were as follows: (1) the
catheter ablation targeting the isthmus of prior-MIVT showed a
satisfactory follow-up result; (2) the recurrence rate in the non-inducible group was signiﬁcantly lower than that in the inducible
group, and (3) approximately one quarter of the patients died after
the RFCA during 41 months of follow-up, mostly due to non-
cardiac causes.
4.2. An optimal end point of catheter ablation of a prior-MI
A better outcome was previously reported for patients in whom
a critical isthmus of the VT could be identiﬁed, than in those in
whom an isthmus could not be characterized [8]. Conventional
electrophysiological maneuvers such as entrainment mapping and
VT-mapping, facilitate an understanding of the circuit in VT. For
the patients who hemodynamically collapsed during VT, electro-
anatomical mapping systems enabled us to perform substrate
mapping during sinus rhythm. Volkmer et al. reported no sig-
niﬁcant differences between VT-mapping or substrate mapping in
terms of freedom from VT recurrence [9]. These two different
strategies do not reduce the importance of aiming for a critical
isthmus, but mean that careful mapping of the infarct area or
pacing maneuvers are as effective in identifying the critical
channels as VT-mapping. In terms of an endpoint, targeting LP
abolition seems to be effective and simple [2], but it tends to
require more RF applications and has the potential risk of partial
damage to the critical isthmus, resulting in edema formation in the
surrounding area. We have a dilemma regarding how extensively
the low voltage area should be ablated.
Recently, Pauriah et al. attempted to determine the possibility
of using RFCA as the ﬁrst-line treatment for prior-MIVT. They
showed the effects of a stepwise algorithm based on acute success,
repeat electrophysiological studies, and recurrence of VT [10]. A
stepwise algorithm is attractive, but it is still difﬁcult to decide the
endpoint during the procedure. Acute success is typically deﬁned
by the non-inducibility with programmed electrical stimulation, at
the end of the ablation. In the setting of patients with electrical
storms, programmed stimulation is a reasonable marker for pre-
vention of electrical storm recurrence [11]. In a clinical setting, a
variety of conditions affect the assessment of a successful proce-
dure such as the EF, low voltage area, inability to document the
clinical VT morphologies, hemodynamically stable VT, and difﬁ-
culty in the induction of VT before the procedure.
In this study, we assessed the impact of the catheter ablation
for the patients with prior-MI. In order to avoid extensive ablation,
a modest stimulation protocol with up to two extra stimuli was
applied to induce VT. Our goal was not to abolish all delayed
potentials, but to target the isthmus, which formed a circuit of
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Fig. 1. A representative case for non-inducible group. (A) The mid-diastolic potentials (arrows) recorded during VT. (B) Entrainment pacing at that point showing the exit to
the central isthmus of the circuit. (C) The bipolar endocardial voltage map of the case. Red tags show ablation points. (D) The VT terminated 3 seconds after RF application.
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ing VT mapping was not associated with a better prognosis, but
the sample size seemed to be underpowered statistically in order
to show a deﬁnite beneﬁt. Precise mapping targeting the isthmus
could be a way to improve the long-term success. The inducibility
at the end of the procedure is still a powerful predictor that helps
evaluate VT recurrence and fragility in a patient. According to
previous studies, most of the programmed stimulation protocols
included up to three or even four extra stimuli [12]. If a more
difﬁcult end point were set, it would require more procedure time
and RF applications. Our procedure time (193745 min) and RF
lesions (18711 times) were acceptable for minimizing any
unexpected complications. Our ablation strategy, targeting the
critical isthmus and exit of the VT circuit, beneﬁts from under-
standing the entire picture of the VT circuit and requires the
provider to become proﬁcient in a variety of new and classical
electrophysiological maneuvers in order to analyze the local
potential.
Compared to the study with the largest number of patients
with prior-MIVT [13], our long-term data provided similar results
with regards to freedom from VT recurrence. In that study, VT was
inducible before the procedure in 93.8% of the patients. With a
median of 634 days per patient, the group whose VT was rendered
non-inducible had signiﬁcantly greater freedom from VT recur-
rences when compared with the group in whom the VT remainedinducible (61.3% vs. 45.4%, respectively; po0.001). Non-
inducibility was independently also associated with lower mor-
tality (adjusted hazard ratio: 0.65; 95% conﬁdence interval: 0.53–
0.79; po0.001). In our study, although the programmed stimu-
lation protocol was modest, inducibility was almost the same at
the baseline (96%). Freedom from VT or VF recurrence was almost
similar (55% in the non-inducible group vs. 39% in the inducible
group, at the 5-year follow-up visits). It is very important to
conﬁrm the effect of catheter ablation with inducibility at the end
of the procedure, but it is still necessary to improve the long-term
success among patients in whom some VTs remain inducible or VT
is non-inducible before ablation. In our study, VTs were not
inducible at the baseline in 2 patients with an ICD; a 12-lead ECG
of VT was obtained previously due to the slower VT cycle length
than the ICD setting in one patient, and no clinically relevant ECG
was obtained in the other patient. Information about clinical VTs is
a key for a better procedure. Although patients with an ICD
sometimes have limited information about VT, we should make
efforts to get as many clinical 12-lead ECGs of VT as possible before
the procedure.
With regard to mortality, our study showed no difference
between the two groups. This could be explained by the higher
rate of non-cardiac death and the high usage of amiodarone after
ablation.
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The ﬁrst limitation is that this was an observational study and
not a randomized controlled study. ICDs were not implanted in all
patients because of the patient’s preference or a preserved EF. All
sudden deaths in this study occurred in patients with an ICD, but
two patients in the inducible group died due to unknown causes.
Second, an epicardial approach was attempted in four patients
in the second procedure. In this study, only the ﬁrst procedure was
taken into consideration. Epicardial arrhythmogenic substrate may
have existed, but it is usually not so associated with MIVT.
Third, the study size was too small to allow for division into
subgroups. A greater number of patients will be needed for further
study, and our strategy needs to be evaluated.5. Conclusions
Catheter ablation in patients with prior MI, targeting not all of
the delayed potentials but the isthmus, showed a satisfactory
follow-up result. Subsequent non-inducibility showed an even
higher rate of freedom from VT or VF. The incidence of the freedom
from VT or VF in the non-inducible result group was 69% during a
5-year follow-up.Conﬂict of interest
All authors declare no conﬂict of interest related to this study.Grant
None.Acknowledgments
The authors are indebted to Harushi Niu, Koji Katayama,
Tomoaki Ito, and Ayaka Takeo for their assistance in the electro-
physiological assessment. The authors would also like to thank
Kyohei Yamaji for his scientiﬁc suggestions.References
[1] Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a deﬁbrillator
in patients with myocardial infarction and reduced ejection fraction. N Engl J
Med 2002;346:877–83.
[2] Vergara P, Trevisi N, Ricco A, et al. Late potentials abolition as an additional
technique for reduction of arrhythmia recurrence in scar related ventricular
tachycardia ablation. J Cardiovasc Electrophysiol 2012;23:621–7.
[3] Goya M, Fukunaga M, Hiroshima K, et al. Long-term outcomes of catheter
ablation of ventricular tachycardia in patients with structural heart disease. J
Arrhythm 2015;31:22–8.
[4] Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for
management of patients with ventricular arrhythmias and the prevention of
sudden cardiac death: a report of the American College of Cardiology/Amer-
ican Heart Association Task Force and the European Society of Cardiology
Committee for Practice Guidelines (writing committee to develop guidelines
for management of patients with ventricular arrhythmias and the prevention
of sudden cardiac death). J Am Coll Cardiol 2006;48:e247–346. http://dx.doi.
org/10.1016/j.jacc.2006.07.010.
[5] Baerman JM, Morady F, de Buitleir M, et al. A prospective comparison of
programmed ventricular stimulation with triple extrastimuli versus single and
double extrastimuli during infusion of isoproterenol. Am Heart J
1989;117:342–7.
[6] Stevenson WG, Friedman PL, Kocovic D, et al. Radiofrequency catheter abla-
tion of ventricular tachycardia after myocardial infarction. Circulation
1998;98:308–14.
[7] Hsia HH, Lin D, Sauer WH, et al. Anatomic characterization of endocardial
substrate for hemodynamically stable reentrant ventricular tachycardia:
Identiﬁcation of endocardial conducting channels. Heart Rhythm 2006;3:503–
12.
[8] de Chillou C, Lacroix D, Klug D, et al. Isthmus characteristics of reentrant
ventricular tachycardia after myocardial infarction. Circulation 2002;105:726–
31.
[9] Volkmer M, Ouyang F, Deger F, et al. Substrate mapping vs. tachycardia
mapping using CARTO in patients with coronary artery disease and ventricular
tachycardia: impact on outcome of catheter ablation. Europace 2006;8:968–
76.
[10] Pauriah M, Cismaru G, Magnin-Poull I, et al. A stepwise approach to the
management of postinfarct ventricular tachycardia using catheter ablation as
the ﬁrst-line treatment: a single-center experience. Circ Arrhythm Electro-
physiol 2013;6:351–6.
[11] Carbucicchio C, Santamaria M, Trevisi N, et al. Catheter ablation for the
treatment of electrical storm in patients with implantable cardioverter-deﬁ-
brillators: short- and long-term outcomes in a prospective single-center study.
Circulation 2008;117:462–9.
[12] Ghanbari H, Baser K, Yokokawa M, et al. Noninducibility in postinfarction
ventricular tachycardia as an end point for ventricular tachycardia ablation
and its effects on outcomes: a meta-analysis. Circ Arrhythm Electrophysiol
2014;7:677–83.
[13] Yokokawa M, Kim HM, Baser K, et al. Predictive value of programmed ven-
tricular stimulation after catheter ablation of post-infarction ventricular
tachycardia. J Am Coll Cardiol 2015;65:1954–9.
